Report cover image

Passenger Car Motor Oil Market Size, Share & Trends Analysis Report By Grade (Mineral, Synthetic), By Viscosity Grade (Low Viscosity Grades (0W-16, 0W-20, 5W-20), By Engine Type, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033

Publisher Grand View Research
Published Dec 08, 2025
Length 80 Pages
SKU # GV20723776

Description

Passenger Car Motor Oil Market Summary

The global passenger car motor oil market size was estimated at USD 30.9 billion in 2024 and is projected to reach USD 54.5 billion by 2033, growing at a CAGR of 6.7% from 2025 to 2033. The global passenger-car fleet continues to expand, particularly in emerging economies, leading to increased demand for routine engine maintenance and lubrication.

Increased vehicle usage, longer average vehicle lifespan, and growing ownership rates directly boost the consumption of passenger car motor oil (PCMO) products across both OEM and aftermarket channels.

Automakers’ focus on fuel efficiency, lower emissions, and advanced engine technologies (turbocharged, GDI, hybrid engines) is driving a strong transition toward premium synthetic and semi-synthetic motor oils. These formulations deliver extended drain intervals, improved thermal stability, and enhanced engine protection, thereby accelerating the growth of PCMO market value.

Rapid growth of independent service stations, quick-lube centers, and local distributors in Asia, Africa, and Latin America is creating strong opportunities for PCMO suppliers to expand market penetration. As vehicle ownership increases and consumers seek cost-effective maintenance options, lubricant brands can expand their distribution networks, introduce localized product lines, and capture a larger share of the aftermarket sales.

Global Passenger Car Motor Oil Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2033. For this study, Grand View Research has segmented the global passenger car motor oil market report based on product, end use, and region:
  • Grade Outlook (Revenue, USD Billion; Volume, Kilotons; 2021 - 2033)
  • Mineral
  • Synthetic
  • Semi-Synthetic
  • Engine Type Outlook (Revenue, USD Billion; Volume, Kilotons; 2018 - 2033)
  • Gasoline
  • Diesel
  • Hybrid (Gasoline+Electric)
  • Viscosity Grade Outlook (Revenue, USD Billion; Volume, Kilotons; 2018 - 2033)
  • Low Viscosity Grades (0W-16, 0W-20, 5W-20)
  • Medium Viscosity Grades (5W-30, 10W-30)
  • High Viscosity Grades (10W-40, 15W-40, 20W-50)
  • Distribution Channel Outlook (Revenue, USD Billion; Volume, Kilotons; 2018 - 2033)
  • Retail
  • OEM
  • Service Centers
  • Others
  • Regional Outlook (Revenue, USD Billion; Volume, Kilotons; 2018 - 2033)
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • Italy
  • Spain
  • France
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Latin America
  • Brazil
  • Argentina
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
Please note The report will be delivered in 2-3 business days upon order notification.

Table of Contents

80 Pages
Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Mechanism
1.2.3. Drug Potency
1.2.4. Service
1.2.5. End Use
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR’s Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information Or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.7.2. Top-Down Analysis
1.7.3. Botton-Up Approach
1.7.4. Multivariate Analysis
1.8. List of Secondary Sources
1.9. List of Abbreviations
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Oral Solid Dosage CDMO Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Technology Landscape
3.4. Pricing Model Analysis
3.5. Tariff Impact Analysis
3.6. Value Chain Analysis
3.6.1. Supply Trends
3.6.2. Demand Trends
3.7. Market Analysis Tools
3.7.1. Porter’s Five Force Analysis
3.7.2. PESTEL by SWOT Analysis
Chapter 4. Oral Solid Dosage CDMO Market: Product Estimates & Trend Analysis
4.1. Product Market Share, 2024 & 2033
4.2. Product Segment Dashboard
4.3. Oral Solid Dosage CDMO Market: Product Movement Analysis
4.4. Global Oral Solid Dosage CDMO Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
4.5. Tablets
4.5.1. Tablets Market Estimates & Forecasts, 2021 to 2033 (USD Million)
4.5.2. Compressed Tablets
4.5.2.1. Compressed Tablets Market Estimates & Forecasts, 2021 - 2033 (USD Million)
4.5.3. Orally Disintegrating Tablets (ODT)
4.5.3.1. Orally Disintegrating Tablets (ODT) Market Estimates & Forecasts, 2021 - 2033 (USD Million)
4.5.4. Chewable Tablets
4.5.4.1. Chewable Tablets Market Estimates & Forecasts, 2021 - 2033 (USD Million)
4.5.5. Bi-layer or Tri-layer Tablets
4.5.5.1. Bi-layer or Tri-layer Tablets Market Estimates & Forecasts, 2021 - 2033 (USD Million)
4.5.6. Sublingual or Buccal Tablets
4.5.6.1. Sublingual or Buccal Tablets Market Estimates & Forecasts, 2021 - 2033 (USD Million)
4.5.7. Others
4.5.7.1. Others Market Estimates & Forecasts, 2021 - 2033 (USD Million)
4.6. Capsules
4.6.1. Capsules Market Estimates & Forecasts, 2021 to 2033 (USD Million)
4.6.2. Hard Gelatin Capsules
4.6.2.1. Hard Gelatin Capsules Market Estimates & Forecasts, 2021 - 2033 (USD Million)
4.6.3. Soft Gelatin Capsules
4.6.3.1. Soft Gelatin Capsules Market Estimates & Forecasts, 2021 - 2033 (USD Million)
4.7. Powder
4.7.1. Powder Market Estimates & Forecasts, 2021 - 2033 (USD Million)
4.8. Granules
4.8.1. Granules Market Estimates & Forecasts, 2021 - 2033 (USD Million)
4.9. Others
4.9.1. Others Market Estimates & Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Oral Solid Dosage CDMO Market: Mechanism Estimates & Trend Analysis
5.1. Mechanism Market Share, 2024 & 2033
5.2. Mechanism Segment Dashboard
5.3. Global Oral Solid Dosage CDMO Market: Mechanism Movement Analysis
5.4. Global Oral Solid Dosage CDMO Market Size & Trend Analysis, by Mechanism, 2021 to 2033 (USD Million)
5.5. Immediate Release
5.5.1. Immediate Release Market Estimates & Forecasts, 2021 - 2033 (USD Million)
5.6. Delayed Release
5.6.1. Delayed Release Market Estimates & Forecasts, 2021 - 2033 (USD Million)
5.7. Controlled Release
5.7.1. Controlled Release Market Estimates & Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Oral Solid Dosage CDMO Market: Drug Potency Estimates & Trend Analysis
6.1. Drug Potency Market Share, 2024 & 2033
6.2. Drug Potency Segment Dashboard
6.3. Oral Solid Dosage CDMO Market: Drug Potency Movement Analysis
6.4. Global Oral Solid Dosage CDMO Market Size & Trend Analysis, by Drug Potency, 2021 to 2033 (USD Million)
6.5. High Potent Drugs
6.5.1. High Potent Drugs Market Estimates & Forecasts, 2021 - 2033 (USD Million)
6.6. Moderate Potent Drugs
6.6.1. Moderate Potent Drugs Market Estimates & Forecasts, 2021 - 2033 (USD Million)
6.7. Low Potent Drugs
6.7.1. Low Potent Drugs Market Estimates & Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Oral Solid Dosage CDMO Market: Service Estimates & Trend Analysis
7.1. Service Market Share, 2024 & 2033
7.2. Service Segment Dashboard
7.3. Oral Solid Dosage CDMO Market: Service Movement Analysis
7.4. Global Oral Solid Dosage CDMO Market Size & Trend Analysis, by Service, 2021 to 2033 (USD Million)
7.5. Contract Development
7.5.1. Contract Development Market Estimates & Forecasts, 2021 - 2033 (USD Million)
7.6. Contract Manufacturing
7.6.1. Contract Manufacturing Market Estimates & Forecasts, 2021 - 2033 (USD Million)
7.7. Packaging and Labelling
7.7.1. Packaging and Labelling Market Estimates & Forecasts, 2021 - 2033 (USD Million)
7.8. Regulatory Affairs
7.8.1. Regulatory Affairs Market Estimates & Forecasts, 2021 - 2033 (USD Million)
7.9. Logistics & Storage
7.9.1. Logistics & Storage Market Estimates & Forecasts, 2021 - 2033 (USD Million)
7.10. Others
7.10.1. Others Market Estimates & Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Oral Solid Dosage CDMO Market: End Use Estimates & Trend Analysis
8.1. End Use Market Share, 2024 & 2033
8.2. End Use Segment Dashboard
8.3. Oral Solid Dosage CDMO Market: End Use Movement Analysis
8.4. Global Oral Solid Dosage CDMO Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
8.5. Large Size Companies
8.5.1. Large Size Companies Market Estimates & Forecasts, 2021 - 2033 (USD Million)
8.6. Medium & Small Size Companies
8.6.1. Medium & Small Size Companies Market Estimates & Forecasts, 2021 - 2033 (USD Million)
8.7. Others
8.7.1. Others Market Estimates & Forecasts, 2021 - 2033 (USD Million)
Chapter 9. Oral Solid Dosage CDMO Market: Regional Estimates & Trend Analysis
9.1. Regional Market Dashboard
9.2. Oral Solid Dosage CDMO Market: Regional Movement Analysis
9.3. Market Size & Forecasts Trend Analysis, 2021 to 2033
9.4. North America
9.4.1. North America Oral Solid Dosage CDMO Market Estimates & Forecasts, By Country, 2021 - 2033 (USD Million)
9.4.2. U.S.
9.4.2.1. Key Country Dynamics
9.4.2.2. Regulatory Framework
9.4.2.3. U.S. Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
9.4.3. Canada
9.4.3.1. Key Country Dynamics
9.4.3.2. Regulatory Framework
9.4.3.3. U.S. Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
9.4.4. Mexico
9.4.4.1. Key Country Dynamics
9.4.4.2. Regulatory Framework
9.4.4.3. Mexico Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
9.5. Europe
9.5.1. Europe Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
9.5.2. UK
9.5.2.1. Key Country Dynamics
9.5.2.2. Regulatory Framework
9.5.2.3. UK Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
9.5.3. Germany
9.5.3.1. Key Country Dynamics
9.5.3.2. Regulatory Framework
9.5.3.3. Germany Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
9.5.4. France
9.5.4.1. Key Country Dynamics
9.5.4.2. Regulatory Framework
9.5.4.3. France Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
9.5.5. Italy
9.5.5.1. Key Country Dynamics
9.5.5.2. Regulatory Framework
9.5.5.3. Italy Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
9.5.6. Spain
9.5.6.1. Key Country Dynamics
9.5.6.2. Regulatory Framework
9.5.6.3. Spain Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
9.5.7. Denmark
9.5.7.1. Key Country Dynamics
9.5.7.2. Regulatory Framework
9.5.7.3. Denmark Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
9.5.8. Sweden
9.5.8.1. Key Country Dynamics
9.5.8.2. Regulatory Framework
9.5.8.3. Sweden Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
9.5.9. Norway
9.5.9.1. Key Country Dynamics
9.5.9.2. Regulatory Framework
9.5.9.3. Norway Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
9.6. Asia Pacific
9.6.1. Asia Pacific Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
9.6.2. Japan
9.6.2.1. Key Country Dynamics
9.6.2.2. Regulatory Framework
9.6.2.3. Japan Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
9.6.3. China
9.6.3.1. Key Country Dynamics
9.6.3.2. Regulatory Framework
9.6.3.3. China Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
9.6.4. India
9.6.4.1. Key Country Dynamics
9.6.4.2. Regulatory Framework
9.6.4.3. India Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
9.6.5. Australia
9.6.5.1. Key Country Dynamics
9.6.5.2. Regulatory Framework
9.6.5.3. Australia Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
9.6.6. South Korea
9.6.6.1. Key Country Dynamics
9.6.6.2. Regulatory Framework
9.6.6.3. South Korea Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
9.6.7. Thailand
9.6.7.1. Key Country Dynamics
9.6.7.2. Regulatory Framework
9.6.7.3. Thailand Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
9.7. Latin America
9.7.1. Latin America Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
9.7.2. Brazil
9.7.2.1. Key Country Dynamics
9.7.2.2. Regulatory Framework
9.7.2.3. Japan Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
9.7.3. Argentina
9.7.3.1. Key Country Dynamics
9.7.3.2. Regulatory Framework
9.7.3.3. China Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
9.8. Middle East and Africa
9.8.1. Middle East and Africa Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
9.8.2. South Africa
9.8.2.1. Key Country Dynamics
9.8.2.2. Regulatory Framework
9.8.2.3. South Africa Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
9.8.3. Saudi Arabia
9.8.3.1. Key Country Dynamics
9.8.3.2. Regulatory Framework
9.8.3.3. Saudi Arabia Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
9.8.4. UAE
9.8.4.1. Key Country Dynamics
9.8.4.2. Regulatory Framework
9.8.4.3. UAE Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
9.8.5. Kuwait
9.8.5.1. Key Country Dynamics
9.8.5.2. Regulatory Framework
9.8.5.3. Kuwait Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
9.8.6. Qatar
9.8.6.1. Key Country Dynamics
9.8.6.2. Regulatory Framework
9.8.6.3. Qatar Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
9.8.7. Oman
9.8.7.1. Key Country Dynamics
9.8.7.2. Regulatory Framework
9.8.7.3. Oman Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
Chapter 10. Competitive Landscape
10.1. Participant Overview
10.2. Company Market Position Analysis
10.3. Company Categorization
10.4. Strategy Mapping
10.5. Company Profiles/Listing
10.5.1. Lonza
10.5.1.1. Company Overview
10.5.1.2. Financial Performance
10.5.1.3. Product Benchmarking
10.5.1.4. Strategic Initiatives
10.5.2. Thermo Fisher Scientific Inc.
10.5.2.1. Company Overview
10.5.2.2. Financial Performance
10.5.2.3. Product Benchmarking
10.5.2.4. Strategic Initiatives
10.5.3. Cambrex Corporation
10.5.3.1. Company Overview
10.5.3.2. Financial Performance
10.5.3.3. Product Benchmarking
10.5.3.4. Strategic Initiatives
10.5.4. Catalent, Inc.
10.5.4.1. Company Overview
10.5.4.2. Financial Performance
10.5.4.3. Product Benchmarking
10.5.4.4. Strategic Initiatives
10.5.5. Siegrfried Holding AG
10.5.5.1. Company Overview
10.5.5.2. Financial Performance
10.5.5.3. Product Benchmarking
10.5.5.4. Strategic Initiatives
10.5.6. Recipharm AB
10.5.6.1. Company Overview
10.5.6.2. Financial Performance
10.5.6.3. Product Benchmarking
10.5.6.4. Strategic Initiatives
10.5.7. CordenPharma International
10.5.7.1. Company Overview
10.5.7.2. Financial Performance
10.5.7.3. Product Benchmarking
10.5.7.4. Strategic Initiatives
10.5.8. Boehringer Ingelheim
10.5.8.1. Company Overview
10.5.8.2. Financial Performance
10.5.8.3. Product Benchmarking
10.5.8.4. Strategic Initiatives
10.5.9. Piramal Pharma Solutions
10.5.9.1. Company Overview
10.5.9.2. Financial Performance
10.5.9.3. Product Benchmarking
10.5.9.4. Strategic Initiatives
10.5.10. Aenova Group
10.5.10.1. Company Overview
10.5.10.2. Financial Performance
10.5.10.3. Product Benchmarking
10.5.10.4. Strategic Initiatives
10.5.11. Almac Group
10.5.11.1. Company Overview
10.5.11.2. Financial Performance
10.5.11.3. Product Benchmarking
10.5.11.4. Strategic Initiatives
10.5.12. Jubilant Pharmova Limited
10.5.12.1. Company Overview
10.5.12.2. Financial Performance
10.5.12.3. Product Benchmarking
10.5.12.4. Strategic Initiatives
10.5.13. Delpharm
10.5.13.1. Company Overview
10.5.13.2. Financial Performance
10.5.13.3. Product Benchmarking
10.5.13.4. Strategic Initiatives
10.5.14. AbbVie Contract Manufacturing
10.5.14.1. Company Overview
10.5.14.2. Financial Performance
10.5.14.3. Product Benchmarking
10.5.14.4. Strategic Initiatives
10.5.15. Next Pharma AB
10.5.15.1. Company Overview
10.5.15.2. Financial Performance
10.5.15.3. Product Benchmarking
10.5.15.4. Strategic Initiatives
10.5.16. Rubicon Research Pvt. Ltd.
10.5.16.1. Company Overview
10.5.16.2. Financial Performance
10.5.16.3. Product Benchmarking
10.5.16.4. Strategic Initiatives
10.5.17. Quotient Sciences
10.5.17.1. Company Overview
10.5.17.2. Financial Performance
10.5.17.3. Product Benchmarking
10.5.17.4. Strategic Initiatives
10.5.18. SPI Pharma
10.5.18.1. Company Overview
10.5.18.2. Financial Performance
10.5.18.3. Product Benchmarking
10.5.18.4. Strategic Initiatives
10.5.19. DPT Laboratories Ltd.
10.5.19.1. Company Overview
10.5.19.2. Financial Performance
10.5.19.3. Product Benchmarking
10.5.19.4. Strategic Initiatives
10.5.20. Alcami Corporation
10.5.20.1. Company Overview
10.5.20.2. Financial Performance
10.5.20.3. Product Benchmarking
10.5.20.4. Strategic Initiatives  

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us